Appointment Type |
Department |
Division |
Rank |
Primary |
Med - Infectious Diseases |
Med - Infectious Diseases |
Professor |
Center |
Center for Women's Reproductive Health |
Center for Women's Reproductive Health |
Professor |
|
Hughes Med-Grad Fellowship Program |
|
Publication |
PUBMEDID |
X, Ghosh SK, Taylor ME, Johnson VA, Emini E, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122,1995. |
|
Saag MS, Holodniy M, Kuritzkes DR, O’Brien WA, Coombs R, Poscher ME, Jacobsen DM, Shaw G, Richman DD, Volberding PA, for the Inernational AIDS-Society-USA. HIV viral load markers in clinical practice. Nature Med 2:625-629,1996. |
|
Wheat J, MaWhinney S, Hafner R, McKinsey D, Chen D, Korzun A, Skahan KJ, Johnson P, Hamill R, Bamberger D, Pappas P, Stansell J, Koletar S, Squires K, Larsen RA, Cheung T, Hyslop N, Lai KK, Schneider D, Kauffman C, Saag M, Dismukes W, Powderly W for the NIAID Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. Treatment of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome. Am J Med 103;223-232,1997. |
|
Carpenter CJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JSG, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the International AIDS Society-USA Panel. JAMA 280:78-86,1998. |
|
Kilby JM, Hopkins S, Venetta TM, DiMassimo B, Cloud GA, Lee JY, Carder L, Johnson R, Nowak MA, Shaw GM, Saag MS. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nature Medicine 4:1302-1307,1998. |
|
Saag MS, Kilby JM. HIV-1 and HAART: A time to cure, a time to kill. Nature Med 5:609-611, 1999. |
|
Saag MS. A review of the FIAU tragedy and its effect on clinical research. J Clin Res Practice 1:21 32,Spring 1999. |
|
Saag MS, Fessel WJ, Kaufman CA, Merrill KW, Ward DJ, Moskovitz BL, Thomas C, Oleka N, Guarnieri JA, Lee J, Brenner-Gati L, Klausner M . Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients (MSG #30). AIDS Res & Human Retrovir 15(16):1413-1417,1999. |
|
Kilby JM, Goepfert PA, Miller AP, Gnann JW, Sillers M, Saag MS, bucy RP. Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report. Ann Intern Med 133:435-438,2000. |
|
Call SA, Saag MS, Westfall AO, Raper JL, Pham SV, Tolson JM, Hellmann NS, Cloud GA, Johnson VA. Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection. JID 183:401-408,2001. |
|
|
|